These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16253870)

  • 1. Angiogenesis inhibitors: an upcoming therapy for cancer and wet age-related macular degeneration.
    Sweeney K
    Drug Discov Today; 2005 Oct; 10(20):1346-8. PubMed ID: 16253870
    [No Abstract]   [Full Text] [Related]  

  • 2. Age-related macular degeneration.
    Brucker AJ
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-angiogenesis drugs as a potential approach in cancer therapy].
    Sela B
    Harefuah; 2000 Oct; 139(7-8):283-9. PubMed ID: 11062974
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitors of neovascularization.
    York J; Glaser B; Murphy R
    J Ophthalmic Nurs Technol; 2000; 19(4):194-7. PubMed ID: 11309996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis as a therapeutic target.
    Ferrara N; Kerbel RS
    Nature; 2005 Dec; 438(7070):967-74. PubMed ID: 16355214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choking off a tumor's blood supply.
    Morrow T
    Manag Care; 2004 Jan; 13(1):50-1. PubMed ID: 14763283
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
    Folkman J
    Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the potential impact of using intravitreal angiostatic agents for wet macular degeneration on service capacity in a large retinal referral centre.
    Cheung CM; Peh KK; Yang Y
    Eye (Lond); 2007 Aug; 21(8):1121-2. PubMed ID: 17525768
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
    Querques G
    Am J Ophthalmol; 2009 Feb; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene silencing in wet age-related macular degeneration.
    Arjamaa O
    Lancet; 2006 Aug; 368(9536):630-1. PubMed ID: 16920453
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ziemssen F; Heiduschka P; Schraermeyer U;
    Retina; 2007 Oct; 27(8):1154-6; author reply 1156-8. PubMed ID: 18040264
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy for age-related macular degeneration.
    Patel S
    Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology beyond neovascularization: new targets in age-related macular degeneration.
    Heier JS
    Retina; 2009 Jun; 29(6 Suppl):S39-41. PubMed ID: 19553799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF and age-related macular degeneration.
    McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
    Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravitreal medication for age-related macular degeneration (AMD)].
    Maier M; Fischer E; Winkler von Mohrenfels C; Lohmann C
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):R1-23; quiz R24-7. PubMed ID: 17260312
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-angiogenic therapeutic strategies and inhibition of tumor growth].
    Bachelot T
    Ann Pathol; 1999; 19(5 Suppl):S74-5. PubMed ID: 10599459
    [No Abstract]   [Full Text] [Related]  

  • 17. American Association for Cancer Research 98th Annual Meeting. Angiogenesis and anti-angiogenesis in cancer.
    Duda DG
    IDrugs; 2007 Jun; 10(6):366-9. PubMed ID: 17641996
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiangiogenic therapy for cancer: an update.
    Shojaei F; Ferrara N
    Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Angiogenesis.
    Büning H; Hacker UT
    Adv Exp Med Biol; 2016; 917():261-85. PubMed ID: 27236560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
    Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
    Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.